196 related articles for article (PubMed ID: 33576305)
1. Stereology in Grading and Prognosis of Canine Cutaneous Mast Cell Tumors.
Casanova M; Branco S; Veiga IB; Barros A; Faísca P
Vet Pathol; 2021 May; 58(3):483-490. PubMed ID: 33576305
[TBL] [Abstract][Full Text] [Related]
2. Internal Tandem Duplication of Exon 8 of
Brocks BAW; Bertram CA; Bartel A; Kirpensteijn J; Collins-Webb A; Catlin C; Thaiwong T; Kiupel M
Vet Pathol; 2021 Mar; 58(2):315-324. PubMed ID: 33231140
[TBL] [Abstract][Full Text] [Related]
3. Histologic grading of canine mast cell tumor: is 2 better than 3?
Sabattini S; Scarpa F; Berlato D; Bettini G
Vet Pathol; 2015 Jan; 52(1):70-3. PubMed ID: 24513799
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of Ki67, Bax, Bcl-2 and KIT in canine cutaneous mast cell tumours and their relationship with histopathology and prognosis.
Aytemiz Danyer I; Gürel A
Acta Vet Hung; 2024 Jan; 71(3-4):183-192. PubMed ID: 38112689
[TBL] [Abstract][Full Text] [Related]
5. Validation of the prognostic value of histopathological grading or c-kit mutation in canine cutaneous mast cell tumours: a retrospective cohort study.
Takeuchi Y; Fujino Y; Watanabe M; Takahashi M; Nakagawa T; Takeuchi A; Bonkobara M; Kobayashi T; Ohno K; Uchida K; Asano K; Nishimura R; Nakayama H; Sugano S; Ohashi Y; Tsujimoto H
Vet J; 2013 Jun; 196(3):492-8. PubMed ID: 23384436
[TBL] [Abstract][Full Text] [Related]
6. Expression of Ki67, BCL-2, and COX-2 in canine cutaneous mast cell tumors: association with grading and prognosis.
Vascellari M; Giantin M; Capello K; Carminato A; Morello EM; Vercelli A; Granato A; Buracco P; Dacasto M; Mutinelli F
Vet Pathol; 2013 Jan; 50(1):110-21. PubMed ID: 22673539
[TBL] [Abstract][Full Text] [Related]
7. Comparison of 2- and 3-category histologic grading systems for predicting the presence of metastasis at the time of initial evaluation in dogs with cutaneous mast cell tumors: 386 cases (2009-2014).
Stefanello D; Buracco P; Sabattini S; Finotello R; Giudice C; Grieco V; Iussich S; Tursi M; Scase T; Di Palma S; Bettini G; Ferrari R; Martano M; Gattino F; Marrington M; Mazzola M; Elisabetta Vasconi M; Annoni M; Marconato L
J Am Vet Med Assoc; 2015 Apr; 246(7):765-9. PubMed ID: 25794126
[TBL] [Abstract][Full Text] [Related]
8. Exploring the association of intratumoral immune cell infiltrates with histopathologic grade in canine mast cell tumors.
Costa VR; Soileau AM; Liu CC; Moeller CE; Carossino M; Langohr IM; Withers SS
Res Vet Sci; 2022 Oct; 147():83-91. PubMed ID: 35490489
[TBL] [Abstract][Full Text] [Related]
9. Canine mast cell tumors: utility of stereologic tools in cytology.
Marcos R; Almeida J; Marques J; Moreira R; Dias-Pereira P; Correia-Gomes C; Santos M
J Vet Diagn Invest; 2022 Mar; 34(2):263-267. PubMed ID: 34763591
[TBL] [Abstract][Full Text] [Related]
10. Computerized Calculation of Mitotic Count Distribution in Canine Cutaneous Mast Cell Tumor Sections: Mitotic Count Is Area Dependent.
Bertram CA; Aubreville M; Gurtner C; Bartel A; Corner SM; Dettwiler M; Kershaw O; Noland EL; Schmidt A; Sledge DG; Smedley RC; Thaiwong T; Kiupel M; Maier A; Klopfleisch R
Vet Pathol; 2020 Mar; 57(2):214-226. PubMed ID: 31808382
[TBL] [Abstract][Full Text] [Related]
11. Analysis of risk factors for canine mast cell tumors based on the Kiupel and Patnaik grading system among dogs with skin tumors.
Martins AL; Carvalho FF; Mesquita JR; Gärtner F; Amorim I
Open Vet J; 2021; 11(4):619-634. PubMed ID: 35070857
[TBL] [Abstract][Full Text] [Related]
12. Diagnostic accuracy of pre-treatment biopsy for grading cutaneous mast cell tumours in dogs.
Shaw T; Kudnig ST; Firestone SM
Vet Comp Oncol; 2018 Jun; 16(2):214-219. PubMed ID: 28857446
[TBL] [Abstract][Full Text] [Related]
13. Cytologic Criteria for Mast Cell Tumor Grading in Dogs With Evaluation of Clinical Outcome.
Camus MS; Priest HL; Koehler JW; Driskell EA; Rakich PM; Ilha MR; Krimer PM
Vet Pathol; 2016 Nov; 53(6):1117-1123. PubMed ID: 27034386
[TBL] [Abstract][Full Text] [Related]
14. Nucleomorphometric analysis of canine cutaneous mast cell tumours.
Maiolino P; Cataldi M; Paciello O; Restucci B; De Vico G
J Comp Pathol; 2005; 133(2-3):209-11. PubMed ID: 16045919
[TBL] [Abstract][Full Text] [Related]
15. Stereological estimation of nuclear volume in benign and malignant melanocytic lesions of the skin. Inter- and intraobserver variability of malignancy grading.
Sørensen FB; Ottosen PD
Am J Dermatopathol; 1991 Apr; 13(2):99-107. PubMed ID: 2029094
[TBL] [Abstract][Full Text] [Related]
16. Use of a 2-tier histologic grading system for canine cutaneous mast cell tumors on cytology specimens.
Hergt F; von Bomhard W; Kent MS; Hirschberger J
Vet Clin Pathol; 2016 Sep; 45(3):477-83. PubMed ID: 27483044
[TBL] [Abstract][Full Text] [Related]
17. Nuclear morphometry in cytopathology: a prognostic indicator for canine cutaneous mast cell tumors.
Strefezzi Rde F; Xavier JG; Kleeb SR; Catão-Dias JL
J Vet Diagn Invest; 2009 Nov; 21(6):821-5. PubMed ID: 19901282
[TBL] [Abstract][Full Text] [Related]
18. Immunohistochemical detection of p53 tumor-suppressor protein is a poor indicator of prognosis for canine cutaneous mast cell tumors.
Ginn PE; Fox LE; Brower JC; Gaskin A; Kurzman ID; Kubilis PS
Vet Pathol; 2000 Jan; 37(1):33-9. PubMed ID: 10643978
[TBL] [Abstract][Full Text] [Related]
19. Retrospective outcome evaluation for dogs with surgically excised, solitary Kiupel high-grade, cutaneous mast cell tumours.
Moore AS; Frimberger AE; Taylor D; Sullivan N
Vet Comp Oncol; 2020 Sep; 18(3):402-408. PubMed ID: 31916687
[TBL] [Abstract][Full Text] [Related]
20. Inclusion of fibroblasts and collagen fibrils in the cytologic grading of canine cutaneous mast cell tumors.
Paes PRO; Horta RS; Luza LC; Pierezan F; Costa MP; Lavalle GE
Vet Clin Pathol; 2022 Sep; 51(3):339-348. PubMed ID: 35419864
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
